Market Updates

Chr. Hansen Extends its Probiotics Family

Denmark-based Chr. Hansen has signed an exclusive agreement with biotech company Probiomics Ltd., securing the rights to market the patented probiotic strain Lactobacillus fermentum PCC, which has documented benefits to immune health. Several clinical studies in various indication areas have been conducted involving PCC, which has shown to be effective in relation to atopic dermatitis, as an adjuvant to flu vaccine, and in supporting immune response in athletes.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters